Cargando…
Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
Autores principales: | Liu, Dongsheng, Saeed, Aamir, Majaz, Sidra, Ahmad, Bashrat, Ahmad, Ashfaq, Xie, Yingqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213593/ https://www.ncbi.nlm.nih.gov/pubmed/37237409 http://dx.doi.org/10.1186/s12967-023-04186-4 |
Ejemplares similares
-
Targeting omicron and other reported SARS-CoV-2 lineages by potent inhibitors of main protease 3CL Mpro: Molecular simulation analysis
por: Saeed, Aamir, et al.
Publicado: (2022) -
MBE Emerging Classics 2023
por: Rowe, Heather
Publicado: (2023) -
Ongoing measles outbreaks in Romania, March 2023 to August 2023
por: Lazar, Mihaela, et al.
Publicado: (2023) -
Urgency of COVID-19 vaccination in adolescents: Androgen and estrogen receptors view
por: Kazybay, Bexultan, et al.
Publicado: (2022) -
Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)